Tomoyuki Yokoyama Selected Research

Tomoyuki Yokoyama Research Topics

Disease

5	Heart Failure 01/2012 - 02/2002
3	Myocardial Infarction 01/2019 - 11/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2018 - 01/2007
3	Obesity 09/2018 - 01/2007
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 08/2009
3	Cardiomegaly (Heart Hypertrophy) 12/2012 - 10/2003
2	Myocarditis (Carditis) 05/2022 - 02/2002
2	Atherosclerosis 05/2021 - 01/2014
2	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 01/2014
2	Hypothermia 02/2015 - 01/2014
2	Insulin Resistance 01/2014 - 08/2009
2	Fibrosis (Cirrhosis) 01/2012 - 04/2008
2	Obstructive Sleep Apnea 08/2009 - 01/2008
1	COVID-19 05/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Stable Angina 01/2019
1	Ventricular Tachycardia 11/2017
1	Neointima 11/2016
1	Overnutrition 01/2014
1	Idiopathic Pulmonary Fibrosis 01/2013
1	Vascular Calcification 01/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2013
1	Hypertension (High Blood Pressure) 12/2012
1	Hypertrophy 12/2012
1	Cicatrix (Scar) 01/2012
1	Apnea 01/2008
1	Ischemia 01/2007
1	Inflammation (Inflammations) 01/2007
1	Sarcoidosis (Schaumann Disease) 12/2004
1	Communicable Diseases (Infectious Diseases) 10/2003
1	Hypoxia (Hypoxemia) 07/2002
1	Heart Neoplasms 02/2002
1	Body Weight (Weight, Body) 02/2002
1	Necrosis 02/2002

Drug/Important Bio-Agent (IBA)

5	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2012
4	Fatty Acid-Binding ProteinsIBA 05/2021 - 11/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007 - 02/2002
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2009
3	LeptinIBA 12/2012 - 01/2007
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019 - 09/2018
2	AdipokinesIBA 09/2018 - 01/2008
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2014 - 12/2004
2	Leptin ReceptorsIBA 12/2012 - 01/2007
2	Connective Tissue Growth FactorIBA 01/2012 - 04/2008
2	CytokinesIBA 01/2012 - 02/2002
2	Messenger RNA (mRNA)IBA 01/2007 - 07/2002
1	VaccinesIBA 05/2022
1	TroponinIBA 05/2022
1	mRNA VaccinesIBA 05/2022
1	COVID-19 VaccinesIBA 05/2022
1	Apolipoproteins E (ApoE)IBA 05/2021
1	IncretinsIBA 01/2021
1	AMP-Activated Protein KinasesIBA 01/2019
1	fibroblast growth factor 21IBA 01/2019
1	Becaplermin (PDGF-BB)FDA Link 11/2016
1	Small Interfering RNA (siRNA)IBA 11/2016
1	GlycogenIBA 02/2015
1	Triglycerides (Triacylglycerol)IBA 02/2015
1	Blood Glucose (Blood Sugar)IBA 02/2015
1	Carrier Proteins (Binding Protein)IBA 01/2014
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2013
1	LipidsIBA 01/2013
1	Nonesterified Fatty Acids (NEFA)IBA 01/2013
1	CalciumIBA 01/2013
1	Eicosapentaenoic AcidIBA 01/2013
1	Insulin (Novolin)FDA Link 08/2009
1	N(epsilon)-hexanoyllysineIBA 08/2009
1	p38 Mitogen-Activated Protein KinasesIBA 05/2008
1	Prostaglandins FIBA 05/2008
1	Biomarkers (Surrogate Marker)IBA 04/2008
1	Hemoglobins (Hemoglobin)IBA 01/2008
1	AdiponectinIBA 01/2008
1	Biological ProductsIBA 01/2007
1	AntibodiesIBA 01/2007
1	Hormones (Hormone)IBA 01/2007
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2005
1	AntioxidantsIBA 03/2005
1	Carvedilol (Coreg)FDA LinkGeneric 03/2005
1	ElementsIBA 07/2002
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2002
1	endothelial PAS domain-containing protein 1IBA 07/2002
1	Atrial Natriuretic Factor (ANF)IBA 02/2002
1	Interleukin-18 (Interleukin 18)IBA 02/2002
1	Therapeutic UsesIBA 02/2002

Therapy/Procedure

1	Therapeutics 01/2021
1	Ligation 01/2007